Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study

Saved in:

Bibliographic Details
Published in	Haematologica (Roma) Vol. 102; no. 4; pp. e156 - e159
Main Authors	Salles, Gilles, Schuster, Stephen J., de Vos, Sven, Wagner-Johnston, Nina D., Viardot, Andreas, Blum, Kristie A., Flowers, Christopher R., Jurczak, Wojciech J., Flinn, Ian W., Kahl, Brad S., Martin, Peter, Kim, Yeonhee, Shreay, Sanatan, Will, Matthias, Sorensen, Bess, Breuleux, Madlaina, Zinzani, Pier Luigi, Gopal, Ajay K.
Format	Journal Article
Language	English
Published	Italy Ferrata Storti Foundation 01.04.2017
Subjects	Cancer Life Sciences Online Only Medicine Medical Oncology Rituximab Italy Time analysis France Lymphoma Patients Germany
Online Access	Get full text

Loading…